Janux Therapeutics

Clinical-stage biotech developing tumor-activated immunotherapies

Manager – Clinical Supply Chain - Ancillary Supplies

Supply Chain ManagementConfirmed live in the last 24 hours

Full-timeSan Diego, CA, USAIn-person

About the Job

Requirements

A bachelor's degree in supply chain management, logistics, life sciences, or a related field.
Three to five or more years of experience managing clinical supply chain logistics in a pharmaceutical, biotech, or contract research organization environment.
Working knowledge of clinical trial lifecycles and regulatory guidelines, including ICH/GCP, GMP, and FDA requirements.
Experience sourcing infusion administration devices and ancillary supplies internationally.
General knowledge of infusion systems, IV bags, tubing, filters, syringes, and administration devices used in clinical trials.
Experience managing third-party logistics providers and clinical supply depots.
Strong analytical, problem-solving, and multitasking skills, with effective cross-functional communication and vendor negotiation capabilities.
Ability to work on site in San Diego, California, and authorization to work in the United States.

Responsibilities

Collaborate with Clinical Operations and CMC to determine ancillary supply requirements, build demand projections, and maintain trial-level supply plans.
Work with clinical sites and vendors to identify administration systems, infusion supplies, and locally available ancillary materials.
Support site onboarding by reviewing site-specific supply requirements.
Evaluate site-specific administration supplies and compare them with approved dosing configurations.
Establish and manage strategic relationships with global ancillary supply and kitting vendors, including vendor selection, qualification, performance oversight, forecasting, and issue resolution.
Coordinate procurement activities; manage external vendors, depots, and couriers; and oversee import/export documentation.
Monitor site and depot inventory levels, track shipments, manage product expiration dates, and prevent site stock-outs.
Partner with Clinical Operations, Quality Assurance, Regulatory Affairs, CMC, and trial management teams to align supply strategies with study milestones.
Identify supply chain risks, develop mitigation plans, and resolve site delivery issues.
Establish and maintain relationships with ancillary component suppliers.
Support investigations related to ancillary supply deviations, supply shortages, or compatibility concerns.
Support global Phase 1 through Phase 3 clinical studies in oncology and autoimmune diseases.
Ensure supply chain and logistics activities comply with Good Manufacturing Practices (GMP), Good Clinical Practice (GCP), and local regulatory standards.

Desired Qualifications

Experience supporting biologics, monoclonal antibodies, antibody-drug conjugates, or protein therapeutics.

Salary Range: 146000 to 161000 (Currency: USD) (Pay period: per-year-salary)

The Manager of Ancillary Supplies oversees the planning, sourcing, forecasting, and global distribution of non-investigational dosing supplies required to conduct clinical trials. This role is critical to ensuring investigational products can be administered safely and consistently across global clinical sites. The individual will collaborate with Clinical Operations, CMC, vendors, and clinical sites to ensure the availability of compatible ancillary materials and administration systems, supporting uninterrupted patient dosing.

EDUCATION, EXPERIENCE, KNOWLEDGE, SKILLS AND ABILITIES

Collaborate with Clinical Operations and CMC to determine ancillary supply requirements, build demand projections, and maintain trial-level supply plans

Work directly with clinical sites and vendors to identify administration systems, infusion supplies, and locally available ancillary materials

Support site onboarding by reviewing site-specific supply requirements

Evaluate site-specific administration supplies and compare them to approved dosing configurations

Establish and manage strategic relationships with global ancillary supply and kitting vendors, including vendor selection, qualification, performance oversight, forecasting, and issue resolution

Coordinate procurement activities, manage external vendors, depots, couriers, and oversee import/export documentation

Monitor site and depot inventory levels, track shipments, manage product expiration dates, and prevent site stock-outs

Partner with Clinical Operations, Quality Assurance, Regulatory Affairs, CMC, and trial management teams to align supply strategies with study milestones

Proactively identify supply chain risks, develop mitigation plans, and resolve site delivery issues

Establish and maintain relationships with ancillary component suppliers.

Support investigations related to ancillary supply deviations, supply shortages, or compatibility concerns.

Supports global Phase 1 through Phase 3 clinical studies in oncology and autoimmune diseases.

Ensure all supply chain and logistics activities adhere to Good Manufacturing Practices (GMP), Good Clinical Practice (GCP), and local regulatory standards.

REQUIRED EDUCATION, EXPERIENCE, SKILLS, AND ABILITIES

Bachelor’s degree in supply chain management, logistics, life sciences, or a related field.
3 to 5+ years of experience managing clinical supply chain logistics in a pharmaceutical, biotech, or CRO environment.
Working knowledge of clinical trial lifecycles and regulatory guidelines (ICH/GCP, GMP, FDA).
Experience supporting biologics, monoclonal antibodies, ADCs, or protein therapeutics preferred
Experience sourcing infusion administration devices and ancillary supplies internationally
General knowledge of infusion systems, IV bags, tubing, filters, syringes, and administration devices used in clinical trials.
Experience managing third-party logistics providers and clinical supply depots
Strong analytical, problem-solving, and multi-tasking skills, alongside effective cross-functional communication and vendor negotiation capabilities

Job Type: Full-time

Benefits:

·Annual bonus program

·Incentive stock option plan

·401k plan with flat non-elective employer contribution

·Comprehensive medical insurance with 90-100% employer-paid premiums

·Dental and vision insurance

·HSA, FSA, and supplemental insurance plans (life, disability, accident, critical illness, hospital indemnity)

·Unlimited PTO

·Generous holiday schedule; includes summer and winter company shutdown

·Relocation assistance

Schedule:

·Monday to Friday

Work authorization:

·United States (Required)

Additional Compensation:

·Annual targeted bonus %

Work Location:

·On site (San Diego, CA)

EQUAL OPPORTUNITY EMPLOYER:

Janux Therapeutics, Inc. is an equal opportunity employer that is committed to providing a work environment free of harassment and discrimination based upon a protected category, as well as an environment free from retaliation for protected activity.

Notice to Recruiters and Third-Party Agencies

The Talent Acquisition team manages the recruitment and employment process for Janux. To protect the interests of all parties involved, Janux will only accept resumes from a recruiter once a fully-executed search agreement is in place. Agencies are hereby specifically directed not to contact Janux employees directly in an attempt to present candidates. Janux will consider any candidate for whom an Agency and/or Recruiter has submitted an unsolicited resume to have been referred, free of any charges or fees.

About the Company

Janux Therapeutics

Clinical-stage biotech developing tumor-activated immunotherapies

Janux Therapeutics develops cancer immunotherapies that activate the immune system inside tumors to attack cancer while sparing healthy tissue. Its products are tumor-activated and use a proprietary platform masking technology to reduce toxic side effects and improve efficacy compared with traditional T cell engagers. The company advances drug candidates through clinical trials, aiming for regulatory approval and eventual commercialization, with revenue expected from partnerships, licensing, and the sale of approved therapies. Its lead program JANX007 is being evaluated in a Phase 1 trial (ENGAGER PSMA 01) for metastatic prostate cancer to assess safety and preliminary effectiveness.

Company size: 51-200
Company stage: IPO
Headquarters: San Diego, CA
Founded: 2017

Recently Posted Jobs

Explore more opportunities at Janux Therapeutics

See more jobs